Atherectomy Archives - Cardio Flow, Inc. https://cardioflow.net/tag/atherectomy/ A new orbital atherectomy technology Tue, 17 Sep 2024 13:54:31 +0000 en-US hourly 1 https://cardioflow.net/wp-content/uploads/2020/12/cropped-CFI-favicon-600x600-02-32x32.jpg Atherectomy Archives - Cardio Flow, Inc. https://cardioflow.net/tag/atherectomy/ 32 32 Cardio Flow Adds New 5 French 3-Sphere Driveshaft to its FreedomFlow Orbital Atherectomy Platform https://cardioflow.net/cardio-flow-adds-new-5-french-3-sphere-driveshaft-to-its-freedomflow-orbital-atherectomy-platform/ Tue, 17 Sep 2024 06:00:28 +0000 https://cardioflow.net/?p=13472 The post Cardio Flow Adds New 5 French 3-Sphere Driveshaft to its FreedomFlow Orbital Atherectomy Platform appeared first on Cardio Flow, Inc..

]]>

September 17, 2024—Cardio Flow, Inc. has added a new option to its FreedomFlow® orbital atherectomy platform. The new 5 French 3-sphere driveshaft adds a third option to the FreedomFlow platform, joining two 5-sphere driveshafts (5 French and 6 French) for the treatment of complex peripheral artery disease (PAD).

FreedomFlow’s diamond-coated spheres are designed to power through complex vessel blockages by harnessing the power of angular momentum—a rotational vortex that puts three to five diamond-coated spheres in constant contact with the vessel wall, whether advancing or retracting. This modern mechanism of action gives physicians a highly efficient, effective, and flexible way to treat complex PAD in vessels ranging from 2 mm to 8 mm in diameter.

5 Fr 3-sphere is approximately 1.5 mm in diameter (0.062″) and treats vessels 2 mm – 4 mm

5 Fr 5-sphere is approximately 1.5 mm in diameter (0.062”) and treats vessels 2 mm – 4 mm

6 Fr 5-sphere is approximately 2.0 mm in diameter (0.082″) and treats vessels 4 mm – 8 mm

Steve Crowell, Vice President of Sales and Marketing, noted,

The sphere configuration in the new 5 French 3-sphere driveshaft offers physicians enhanced precision and flexibility for treating complex PAD. This advancement improves navigation through challenging anatomy, allowing for more effective treatments while ensuring control and ease of use. We’re excited to continue expanding our portfolio with advanced tools that improve patient outcomes.”

Read more about FreedomFlow’s modern mechanism of action.

The post Cardio Flow Adds New 5 French 3-Sphere Driveshaft to its FreedomFlow Orbital Atherectomy Platform appeared first on Cardio Flow, Inc..

]]> Cardio Flow completes enrollment within its FAST II Clinical Trial of the FreedomFlow Orbital Atherectomy System https://cardioflow.net/cardio-flow-completes-enrollment-within-its-fast-ii-clinical-trial-of-the-freedomflow-orbital-atherectomy-system/ Tue, 02 Feb 2021 17:04:20 +0000 https://cardioflow.net/?p=10459 The post Cardio Flow completes enrollment within its FAST II Clinical Trial of the FreedomFlow Orbital Atherectomy System appeared first on Cardio Flow, Inc..

]]>

February 2, 2021—Cardio Flow, Inc., announces completion of the enrollment phase of its FreedomFlow® Orbital Atherectomy device within its FAST II clinical trial, “Evaluation of the Cardio Flow FreedomFlow™ Orbital Circumferential Atherectomy System to Treat Peripheral Artery Disease.”

The study is evaluating the safety and effectiveness of the Cardio Flow FreedomFlow Orbital Circumferential Atherectomy System for atherosclerotic plaque removal and vessel compliance modification in de novo native target lesions in the peripheral vasculature of the lower extremities.

The study enrolled a total of 112 patients at 13 locations with 25 physicians in the United States, and evaluated both an electrically powered and a pneumatically powered user handle.

Device indications for use: The FreedomFlow® Orbital Circumferential Atherectomy System is applied as therapy to remove atherosclerotic plaque within peripheral arterial vessels. The therapy is intended for patients who are acceptable candidates for percutaneous transluminal atherectomy.

CAUTION: Investigational device. Limited by United States law to investigational use.

The post Cardio Flow completes enrollment within its FAST II Clinical Trial of the FreedomFlow Orbital Atherectomy System appeared first on Cardio Flow, Inc..

]]>